3-125232855-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_021964.3(ZNF148):āc.1871A>Gā(p.Asn624Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000867 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Consequence
NM_021964.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF148 | NM_021964.3 | c.1871A>G | p.Asn624Ser | missense_variant | 9/9 | ENST00000360647.9 | NP_068799.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF148 | ENST00000360647.9 | c.1871A>G | p.Asn624Ser | missense_variant | 9/9 | 1 | NM_021964.3 | ENSP00000353863 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000440 AC: 67AN: 152158Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000383 AC: 96AN: 250438Hom.: 0 AF XY: 0.000436 AC XY: 59AN XY: 135324
GnomAD4 exome AF: 0.000911 AC: 1332AN: 1461586Hom.: 0 Cov.: 75 AF XY: 0.000862 AC XY: 627AN XY: 727094
GnomAD4 genome AF: 0.000440 AC: 67AN: 152276Hom.: 0 Cov.: 31 AF XY: 0.000376 AC XY: 28AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The ZNF148 p.Asn624Ser variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs142424101) and in control databases in 109 of 281832 chromosomes at a frequency of 0.0003868 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 102 of 128294 chromosomes (freq: 0.000795), Other in 1 of 7198 chromosomes (freq: 0.000139), African in 3 of 24904 chromosomes (freq: 0.000121), Latino in 2 of 35406 chromosomes (freq: 0.000056) and South Asian in 1 of 30614 chromosomes (freq: 0.000033), but was not observed in the Ashkenazi Jewish, East Asian, or European (Finnish) populations. The p.Asn624 residue is conserved in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at